Medical Oncology

Uzm. Dr. Erkut Demirciler

Doctor and researcher İzmir Şehir Hastanesi İzmir
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Publications18 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-9747-3784ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046789/doktorlarimiz.html#erkut-demircilersaglik.gov.tr

Scientific work

Publications

18 publications

  1. Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16868-5 Open-access full textSource: OpenAlex

  2. Comparison of Baseline Systemic Inflammatory Indicators in Preoperative Treatment of Gastric Carcinoma

    Preprints.org, 2026

    DOI 10.20944/preprints202607.0514.v1 Open-access full textSource: OpenAlex

  3. Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176893 PMID 42739899 Open-access full textSource: OpenAlex

  4. Opposing Natural Killer and Macrophage Associations Are Masked Within a CD16/IL-15/IL-15RA Composite Score in Metastatic Urothelial Carcinoma

    International Journal of Molecular Sciences, 2026

    DOI 10.3390/ijms27208943 PMID 42941720 Open-access full textSource: ORCID

  5. Clinicopathological features and survival of early-onset colon cancer: a SEER-based analysis of 156,031 curative-intent surgical patients

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1969236 Open-access full textSource: ORCID

  6. Neoadjuvant TCHP for Stage II-III HER2-positive Breast Cancer: A Real-world Cohort

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-1 Open-access full textSource: ORCID

  7. Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a candidate prognostic biomarker and therapeutic target in bladder cancer

    Discover oncology, 2026

    DOI 10.1007/s12672-026-05310-8 PMID 42185660 Open-access full textSource: ORCID

  8. Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15684-1 PMID 41634619 Open-access full textSource: ORCID

  9. Ovarian Cancer

    IntechOpen eBooks, 2026

    DOI 10.5772/intechopen.1016353 Open-access full textSource: OpenAlex

  10. Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

    Medicina, 2025

    DOI 10.3390/medicina61050776 PMID 40428735 Open-access full textSource: OpenAlex

View all 18 publications